Pneumococcal disease in sub-Saharan African children: what is the effectiveness of the pneumococcal conjugate vaccine?
Afr. j. respir. Med
; 4(1): 8-15, 2008. ilus
Article
in English
| AIM
| ID: biblio-1257891
Responsible library:
CG1.1
ABSTRACT
Streptococcus pneumoniae is still a leading cause of morbidity and mortality among children in developing countries. Young children represent a high-risk group for severe pneumococcal disease; not only because of their physio-logical susceptibility but also because polysaccharide vaccines are not effective for them. Pneumococcal conjugate vaccines have shown a high protection against pneumococcal diseases all over the world. Therefore; the expanded use of this vaccine must be considered as a major world health priority
Search on Google
Index:
AIM (Africa)
Main subject:
Pneumococcal Infections
/
Streptococcus pneumoniae
/
Vaccines
/
Child
/
Risk Factors
/
Review
Type of study:
Etiology study
/
Risk factors
Language:
English
Journal:
Afr. j. respir. Med
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS